Anti-snoring Devices Market Size, Share & Industry Analysis, By Device Type (Mandibular Advancement Devices, Tongue Retaining Devices (TRDs), Nasal devices, CPAP Machines & Accessories, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2025-2032

The global anti-snoring devices market size was valued at USD 1.07 billion in 2024. The market is projected to grow from USD 1.15 billion in 2025 to USD 1.94 billion by 2032, exhibiting a CAGR of 7.7% during the forecast period. North America dominated the anti-snoring devices market with a market share of 40.18% in 2024.

Anti-snoring devices help to reduce or prevent snoring by keeping the airway open during sleep. These are non-invasive devices that target key causes of snoring, such as airway obstruction or vibration of throat tissues. The most common types include mandibular advancement devices (MADs), tongue retaining devices (TRDs), chin straps, and nasal dilators. These devices are also used to manage both simple snoring and cases of obstructive sleep apnea (OSA). The increasing penetration of OTC anti-snoring devices among the regular snoring population, mainly due to sleep apnea and other conditions is supporting the market’s growth.

The market is dominated by major players such as ResMed, Fisher & Paykel Healthcare Limited, and SomnoMed due to a strong foothold globally and a diversified portfolio.

MARKET DYNAMICS

MARKET DRIVERS

Rising Prevalence of Sleep Disorders to Propel Market Growth

The increasing prevalence of sleep disorders, such as obstructive sleep apnea (OSA) and snoring, is among the major drivers for the adoption of anti-snoring devices. Health organizations estimate that millions of individuals globally suffer from these disorders that lead to cardiovascular diseases, excessive daytime fatigue, as well as cognitive issues. Increasing awareness about associated complications from untreated snoring and apnea, enables more people to take effective measures that ensure good sleep.

Anti-snoring devices offer a less invasive and less expensive alternative therapy compared to airway pressure therapy and surgical interventions, increasing its popularity. Additionally, innovations that enhance comfort and efficacy are leading to wider use among customers, supporting the global anti-snoring devices market growth.

• For instance, according to the data from the National Center for Biotechnology Information (NCBI) in April 2025, an estimated 936.0 million adults aged 30-69 have mild to severe obstructive sleep apnea (OSA) globally.

MARKET RESTRAINTS

Limited Consumer Awareness and Adoption to Restrict Market Expansion

Despite the increasing prevalence of sleep disorders, one key deterrent to the anti-snoring devices is limited customer awareness and resistance toward such products. A large number of customers are unaware of snoring as a disease, and therefore feel less inclined to take measures to correct it. Customers also consider antisnoring devices as less comfortable or less effective by anecdotal experiences, restricting their wider acceptability.

Moreover, the lack of accessibility to proper diagnosis and limited knowledge about how to treat these conditions in developing and middle-income countries are also restricting its penetration.

• According to the data published by Sleep Doctor Holdings, LLC., in April 2023, around 40.3% of the U.S. individuals diagnosed with sleep apnea have not tried any treatment.

MARKET OPPORTUNITIES

Expansion into Emerging Markets will Assist Product Sales and Lucrative Growth

In recent years, there has been an increase in disposable income and awareness of sleep health in Asia Pacific, Latin America, and parts of Africa. In response, governments and healthcare organizations in these regions are also improving diagnostic facilities, boosting the diagnosis and treatment of sleep disorders. Moreover, the affordability of anti-snoring devices compared to clinical treatments is making them attractive for cost-sensitive markets. In addition, companies are focusing on localized awareness programs and adapting new marketing strategies, while launching affordable product lines to expand their regional presence. This is expected to offer opportunities for partnering with local healthcare providers and digital platforms, thereby helping manufacturers build trust and raise awareness of anti-snoring devices among consumers, and support the market expansion.

MARKET CHALLENGES

Competition from Airway Pressure Therapy Devices and Surgical Therapies Obstruct Growth

Despite high demand for nasal devices and oral appliances, positive airway pressure therapy devices remain the significant choice for treating obstructive sleep apnea (OSA), a major cause of chronic snoring. As a result, these devices are being widely prescribed by healthcare professionals. They are often covered by insurance, making them a preferred option for patients with moderate to severe obstructive sleep apnea (OSA).

Similarly, surgical interventions such as radiofrequency ablation, Uvulopalatopharyngoplasty (UPPP), or implant-based solutions offer long-term relief, reducing the reliance on over-the-counter anti-snoring devices. This is posing a major challenge for manufacturers to demonstrate efficacy, secure medical validations, and differentiate their products through advancements.

• For instance, according to the data from NCBI, in April 2025, there were around 18,526 surgical encounters for obstructive sleep apnea (OSA) across inpatient and outpatient settings in the U.S. in 2019.

ANTI-SNORING DEVICES MARKET TRENDS

Growing Demand for Non-Invasive Solutions is Emerge as a Key Trend

Recently, the incorporation of sensors, AI algorithms, and Bluetooth connectivity has enabled manufacturers to offer personalized treatment plans that adapt to an individual’s sleep patterns and snoring causes. Smart anti-snoring devices monitor sleep quality in real-time, adjust settings automatically for maximum comfort and effectiveness, and sync data with mobile apps for user feedback and health tracking.

• For instance, in November 2022, ProSomnus Sleep Technologies received FDA 510(k) clearance for its EVO [PH] sleep and snore device, designed to treat mild to moderate obstructive sleep apnea and snoring by precisely adjusting the jaw during sleep. The device is 13% smaller than the previous models, customizable, and optionally equipped with a DentiTrac micro-recorder for compliance monitoring.

This tech-driven innovation is appealing to health-conscious consumers who value data-driven solutions and convenience. Additionally, partnerships with telemedicine platforms are enhancing remote diagnosis and treatment, thereby expanding market reach. As a result, wearable health technology is gaining popularity, embedding smart features into anti-snoring devices that differentiate products and attract users.

Download Free sample to learn more about this report.

Segmentation Analysis

By Device Type

Mandibular Advancement Devices Lead Due to High Demand among OSA & Snoring Population

On the basis of device type, the market is classified into mandibular advancement devices, tongue retaining devices (TRDs), nasal devices, CPAP machines & accessories, and others.

To know how our report can help streamline your business, Speak to Analyst

The mandibular advancement devices segment accounted for the dominant global anti-snoring devices market share in 2024. The growth is attributed to its higher preference among the snoring population. Also, it is preferred in the OSA patients when continuous positive airway pressure (CPAP) therapy is non-tolerable. Moreover, players are investing in marketing of these devices to dentists/sleep clinics to increase their adoption among the snoring population.

• For instance, in August 2024, SomnoMed stated that its mandibular advancement devices have treated around 9.0 million patients worldwide in a year. 

By Distribution Channel

Increasing Number of Retail Pharmacies Propelled Segment Growth

Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

In 2024, the global market was dominated by retail pharmacies owing to the rising number of retail pharmacies worldwide, further increasing the availability and accessibility of anti-snoring devices. Moreover, increasing supply agreements directly between these channels and manufacturers is also expected to contribute to the segment’s expansion with an estimated 38.9% share in 2025.

• In October 2024, Amazon Pharmacy revealed plans to speed up its rollout by opening new pharmacy locations and introducing fast, free prescription medication delivery in 20 additional U.S. cities in 2025.

The online pharmacies segment is projected to grow at a CAGR of 8.3% during the forecast period.

Anti-snoring Devices Market Regional Outlook

By geography, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

[tEVmSsLLFs]

North America held the dominant share in 2023 valuing at USD 0.40 billion and also took the leading share in 2024, with USD 0.43 billion. The growth is attributed to the significant treatment rate of obstructive sleep apnea and regular snoring patients in the U.S. and Canada due to higher prevalence of the snoring population. In 2025, the U.S. market is estimated to reach USD 0.43 billion.

• According to the data from the American Medical Association, in April 2024, around 90.0 million individuals in the U.S. snore at one time or another. However, 37.0 million of those adults snore regularly.

Europe and Asia Pacific are projected to expand notably in the forthcoming years, where Europe’s growth rate will be 7.4% which is the second highest among all regions, and reach USD 0.34 billion in 2025. This growth is primarily attributed to the established supply chain and presence of key players, contributing to significant availability and promotion of anti-snoring devices. Backed by these factors, the U.K. anticipates to record USD 0.07 billion, along with Germany and France to hit USD 0.07 billion and USD 0.05 billion respectively in 2025. After Europe, Asia Pacific is estimated to reach USD 0.25 billion in 2025 and secure the third-largest position in the market. India and China are both estimated to reach USD 0.04 billion and 0.11 billion, respectively in 2025.

Latin America in 2025 is set to account USD 0.07 billion bolstered by the increasing awareness of snoring treatment among sleep apnea patients, encouraging key players to expand their presence. In the Middle East & Africa, GCC is set to attain the value of USD 0.02 billion in 2025.

COMPETITIVE LANDSCAPE

Key Industry Players

Strong Foothold and Diversified Product Offerings Strengthen Position of Key Players

In 2024, ResMed, Fisher & Paykel Healthcare Limited, and SomnoMed held the major global anti-snoring devices market share. These companies are focusing on entering the untapped markets through product promotions and awareness campaigns for sleep health. Moreover, they are involved in signing strategic agreements with dental clinics, distributors, and other activities to expand the reach of their product globally. SomnoMed, Glidewell, and ProSomnus Sleep Technologies, are expanding their product portfolio and focusing on increasing geographic presence to gain a significant portion of the market.

LIST OF KEY ANTI-SNORING DEVICES COMPANIES PROFILED

• SomnoMed (Australia)
• ResMed (U.S.)
• Glidewell (U.S.)
• PANTHERA DENTAL (Canada)
• Frantz Design Inc. (U.S.)
• BlueSleep (U.S.)
• ProSomnus Sleep Technologies (U.S.)
• Fisher & Paykel Healthcare Limited (New Zealand)
• Apnea Sciences (U.S.)
• DynaFlex (U.S.)

KEY INDUSTRY DEVELOPMENTS

• March 2025: Signifier Medical Technologies Limited announced a product update for its eXciteOSA device to meet CMS (Medicare & Medicaid) reimbursement requirements, expanding access.
• December 2024: Rotech Healthcare Inc. entered a supplier partnership with Signifier Medical Technologies Limited to distribute the FDA-approved eXciteOSA device to payers, providers, and patients.
• January 2024: SnoreLessNow launched the “Anti-Snore Mouth Guard+” (also known in Europe as SomnoFit-S) in the U.S., via partnership with Swiss manufacturer Oscimed SA, with FDA clearance.
• May 2022: Illusion Aligners introduced an innovative oral anti-snoring device that is simple to wear, comfortable, and effective. This device helps users enjoy a restful, uninterrupted sleep each night.
• February 2021: Signifier Medical Technologies Limited introduced the eXciteOSA device, an innovative anti-snoring solution that delivers electrical muscle stimulation to the tongue using a specially designed mouthpiece.

REPORT COVERAGE

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation